Project Updates

Touchlight

Location: Hampton, London, UK 
Project type: Manufacturing facility redevelopment and expansion 
Expansion completed: May 2023

Touchlight, a biotechnology company based in the UK, redeveloped and expanded its DNA manufacturing facility located in London, UK. The facility produces enzymatic DNA, from research to good manufacturing practice (GMP)-grade.

Colorcon

Location: Johor State, Malaysia 
Project type: Film coating manufacturing facility

Expected Completion: July 2025

Colorcon, a pharmaceutical film coating company based in the US, will build a new manufacturing facility in Johor State, Malaysia, through its subsidiary, Colorcon Malaysia. The facility will produce high-quality and advanced film-coating products.

WuXi Biologics

Location:  Dundalk, Ireland 
Project type: Biologics manufacturing facility 
Estimated Investment: €325m (approximately $394m)

Announced in 2018, the state-of-the-art Wuxi Biologics manufacturing facility began operating in Dundalk in 2021. It is one of the first and largest greenfield pharmaceutical projects by a Chinese company in Ireland. 

Go to article: Home | Clinics ration supplies as cancer drug shortages proliferateGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Owen Mumford Company InsightGo to article: Owen MumfordGo to article: In DepthGo to article: Clinics ration supplies as cancer drug shortages proliferateGo to article: Asian countries prioritise rare disease market access amid stark disparities Go to article: Supercritical fluids advance sterilisation tech in pharmaGo to article: Fighting AMR with a value and subscription modelGo to article: Q&A: How can the US maintain access to essential drugs?Go to article: Inflation reduction act boosts biologic VC financing over small moleculesGo to article: NiproGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: ForewordGo to article: An introduction to artificial intelligenceGo to article: A history of artificial intelligenceGo to article: The impact of artificial intelligence on the pharmaceutical sectorGo to article: Case studies: artificial intelligence in the pharmaceutical industryGo to article: Latest news: artificial intelligence in pharmaGo to article: Q&A with GlobalData thematic analystGo to article: Rx Machina: how AI is transforming pharma sales Go to article: Artificial intelligence innovation: leading companies in in-silico drug discovery Go to article: Leading clinical trials companies in the artificial intelligence theme Go to article: Deal activity related to artificial intelligence in the pharmaceutical industry since 2020Go to article: Artificial intelligence hiring trends in the global pharmaceutical industry since 2020Go to article: Artificial intelligence patent applications in the global pharmaceutical industry since 2020Go to article: Mentions of artificial intelligence in pharmaceutical industry company filings since 2020Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: ListingsGo to article: EventsGo to article: Event: 10th Annual Outsourcing In Clinical Trials UK And Ireland 2023Go to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue